Medical News
Adjuvant Cemiplimab or Placebo in High-Risk Cutaneous Squamous-Cell Carcinoma
New England Journal of Medicine - 31 May 2025 12:00
New England Journal of Medicine, Ahead of Print.
Vepdegestrant, a PROTAC Estrogen Receptor Degrader, in Advanced Breast Cancer
New England Journal of Medicine - 31 May 2025 12:00
New England Journal of Medicine, Ahead of Print.